BIOMAT Database Logo BIOMAT Database Logo

[Coinfection by human immunodeficiency virus and hepatitis C virus]. 1998

R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Servicio de Medicina Interna I, Hospital Clínico San Carlos, Madrid.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008297 Male Males
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C

Related Publications

R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Hepatitis C virus-human immunodeficiency virus coinfection.
February 2012, Liver international : official journal of the International Association for the Study of the Liver,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Human immunodeficiency virus and hepatitis C virus coinfection.
June 1998, European journal of medical research,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Hepatitis C virus and human immunodeficiency virus coinfection in Spain.
August 2003, The Journal of infection,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Human immunodeficiency virus and hepatitis C virus coinfection in Nepal.
March 2014, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Management of hepatitis C virus and human immunodeficiency virus coinfection.
September 2014, Minerva gastroenterologica e dietologica,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Human immunodeficiency and hepatitis C virus coinfection influenced by interferon-gamma.
March 2000, Immunology letters,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Hepatitis C virus/human immunodeficiency virus coinfection: clinical management issues.
July 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
March 2009, Journal of the Indian Medical Association,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection.
December 1999, The American journal of medicine,
R Lana Soto, and J L Mendoza Hernández, and A I Lérida Urteaga, and J L Alvarez-Sala Walther
Understanding human immunodeficiency virus type 1 and hepatitis C virus coinfection.
January 2006, Current HIV research,
Copied contents to your clipboard!